Attendo AB/Skr ATT
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Attendo AB
Attendo AB is a healthcare service provider in the Nordic region, focusing on offering care for older individuals, people with disabilities, and providing social psychiatry services. The company operates through its two main segments: Nursing Homes and Home Care, delivering personalized care solutions. Established in 1985 and headquartered in Danderyd, Sweden, Attendo has expanded its operations across Sweden, Finland, and Denmark. The firm emphasizes quality care and innovative solutions in service delivery, utilizing a decentralized model to adapt to local conditions efficiently. Attendo's strategic approach includes strong regional presence and local community engagement, positioning it as a significant player in the Nordic healthcare sector.
- Ticker
- Skr ATT
- Sector
- Health
- Primary listing
- XSTO
- Employees
- 33,000
- Headquarters
- Danderyd, Sweden
- Website
- www.attendo.com
Attendo AB Metrics
BasicAdvanced
kr 16B
17.57
kr 6.65
1.01
kr 0.90
0.77%
Price and volume
Market cap
kr 16B
Beta
1.01
52-week high
kr 130.20
52-week low
kr 78.80
Average daily volume
231K
Dividend rate
kr 0.90
Financial strength
Current ratio
0.791
Quick ratio
0.661
Long term debt to equity
2.835
Total debt to equity
3.154
Dividend payout ratio (TTM)
13.22%
Interest coverage (TTM)
2.52%
Profitability
EBITDA (TTM)
1,423.4
Gross margin (TTM)
36.90%
Net profit margin (TTM)
5.14%
Operating margin (TTM)
10.34%
Effective tax rate (TTM)
20.65%
Revenue per employee (TTM)
kr 570,000
Management effectiveness
Return on assets (TTM)
4.86%
Return on equity (TTM)
18.72%
Valuation
Price to earnings (TTM)
17.57
Price to revenue (TTM)
0.899
Price to book
3.14
Price to tangible book (TTM)
-4.85
Price to free cash flow (TTM)
6.327
Free cash flow yield (TTM)
15.81%
Free cash flow per share (TTM)
18.462
Dividend yield (TTM)
0.77%
Growth
Revenue change (TTM)
-1.07%
Earnings per share change (TTM)
81.08%
3-year revenue growth (CAGR)
6.19%
10-year revenue growth (CAGR)
6.60%
3-year earnings per share growth (CAGR)
97.73%
10-year earnings per share growth (CAGR)
9.10%
10-year dividend per share growth (CAGR)
12.79%
What the Analysts think about Attendo AB
Analyst ratings (Buy, Hold, Sell) for Attendo AB stock.
Analyst projections of the future price of Attendo AB stock.
Bulls say / Bears say
Occupancy gains are translating into much stronger profits: Q2 lease-adjusted EBITA rose 56% year on year to SEK 321m, while occupancy increased to 88% from 85%. Both business areas improved, suggesting the recovery is not confined to one region. (MFN.se)
Attendo has room to grow capacity and add earnings through acquisitions. Management reported about 900 new care places under construction, plans to open roughly 770 over the next 12 months, and said recent acquisitions add around SEK 50m of annual lease-adjusted EBITA before synergies. (Earningscalls.dev)
Strong cash generation and lower leverage give Attendo scope to invest and return capital to shareholders. Management reported SEK 1.2bn of rolling 12-month free cash flow and leverage of 1.1 times, alongside a new SEK 250m share buyback programme. (Earningscalls.dev)
Municipal scrutiny creates legal and reputational risk for a provider dependent on public contracts. Linköping reported Attendo to police over alleged irregularities in home care, and police opened a preliminary investigation under a suspected aggravated-fraud classification; Attendo disputes the allegations. (Corren)
Reported sales momentum remains weak as Attendo exits contracts and shrinks its operated bed base. First-half net sales fell 0.2% year on year and the number of beds at the end of Q2 was lower than a year earlier, despite better occupancy. (MFN.se)
Public-sector budget pressure may prevent Attendo from passing higher costs through to customers. Its Q1 report lists strained local public finances and price increases that fail to cover cost inflation, or arrive late, as key risks to meeting its objectives. (MarketScreener)
Data summarised monthly by Lightyear AI. Last updated on 8 Oct 2026.
Attendo AB Financial Performance
Revenues and expenses
Attendo AB Earnings Performance
Company profitability
Upcoming events
Funds containing Attendo AB
AllUSDEURGBP
Fund name | Fund size | Skr ATT weighting |
|---|---|---|
iShares Ageing Population$AGED | $953M | 0.13% |
iShares Ageing Population£AGES | $953M | 0.13% |
iShares Ageing Population€AGED | $903M | 0.13% |
Xtrackers MSCI Europe Small Cap£XXSC | $3.6B | 0.10% |
Xtrackers MSCI Europe Small Cap€DX2J | $3.6B | 0.10% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.